Teva Pharmaceutical Industries (TEVA) News Today $16.32 +0.31 (+1.91%) Closing price 03:59 PM EasternExtended Trading$16.32 +0.00 (+0.03%) As of 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TEVA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Envestnet Asset Management Inc. Cuts Stock Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)July 15 at 3:39 AM | marketbeat.comTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Sold by Penserra Capital Management LLCJuly 13, 2025 | marketbeat.comTeva Pharmaceutical (TEVA) Just Flashed a Statistically Viable Signal for Bullish TradersJuly 10, 2025 | msn.comTeva (TEVA) Receives a Buy from Leader Capital MarketsJuly 10, 2025 | theglobeandmail.comStock Traders Buy High Volume of Teva Pharmaceutical Industries Put Options (NYSE:TEVA)July 9, 2025 | americanbankingnews.comTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Holdings Boosted by IFM Investors Pty LtdJuly 8, 2025 | marketbeat.comStock Traders Purchase Large Volume of Teva Pharmaceutical Industries Put Options (NYSE:TEVA)July 7, 2025 | marketbeat.comLeader Capital Markets Keeps Their Buy Rating on Teva (TEVA)July 7, 2025 | theglobeandmail.comTeva Pharmaceutical Industries Ltd. ADR Stock Grades - Barron'sJuly 7, 2025 | barrons.comTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives Average Rating of "Buy" from BrokeragesJuly 7, 2025 | americanbankingnews.comTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives Average Rating of "Buy" from AnalystsJuly 7, 2025 | marketbeat.comTeacher Retirement System of Texas Reduces Holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)July 6, 2025 | marketbeat.comCambridge Investment Research Advisors Inc. Purchases 41,600 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)July 5, 2025 | marketbeat.comHarel Insurance Investments & Financial Services Ltd. Buys 22,044,407 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)July 4, 2025 | marketbeat.comStraight Path Wealth Management Decreases Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)July 3, 2025 | marketbeat.comWCM Investment Management LLC Increases Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)July 3, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Bought by DAVENPORT & Co LLCJuly 3, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Purchased by Sumitomo Mitsui Trust Group Inc.July 2, 2025 | marketbeat.comBillionaire Stanley Druckenmiller Sold Palantir And Buying This Stock InsteadJuly 1, 2025 | 247wallst.comInvestors in Teva Pharmaceutical Industries (NYSE:TEVA) have seen solid returns of 112% over the past three yearsJuly 1, 2025 | finance.yahoo.comAllspring Global Investments Holdings LLC Purchases 5,186,592 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)June 29, 2025 | marketbeat.comSequoia Financial Advisors LLC Increases Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)June 29, 2025 | marketbeat.comAsset Management One Co. Ltd. Reduces Stock Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)June 29, 2025 | marketbeat.comAchmea Investment Management B.V. Sells 122,509 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)June 28, 2025 | marketbeat.comZacks Research Has Optimistic Outlook of TEVA Q1 EarningsJune 27, 2025 | marketbeat.comTeva Releases Q2 2025 Aide MemoireJune 26, 2025 | financialpost.comFTeva Releases Q2 2025 Aide MemoireJune 26, 2025 | globenewswire.comTeva Pharmaceutical Industries (NYSE:TEVA) Given New $23.00 Price Target at UBS GroupJune 26, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Acquired by GHP Investment Advisors Inc.June 26, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd (TEVA) Announces Upcoming Q2 2025 Financial Results Release ...June 25, 2025 | gurufocus.comTeva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025June 25, 2025 | financialpost.comFTeva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025June 25, 2025 | globenewswire.comTeva Pharmaceutical Industries Ltd. - Page 2 - The New York TimesJune 25, 2025 | nytimes.comRetirement Systems of Alabama Takes Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)June 25, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd: Final Data from Teva's PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY (fremanezumab) for the Prevention of Chronic ...June 24, 2025 | finanznachrichten.deTeva Pharmaceutical Industries Presents Final Analysis of PEARL Study Demonstrating Sustained Effectiveness of AJOVY in Migraine Prevention at EAN 2025 Congress - NasdaqJune 24, 2025 | nasdaq.comTEVA Teva Pharmaceutical Industries Limited - Seeking AlphaJune 24, 2025 | seekingalpha.comTeva reports final analysis of migraine prevention trial of AjovyJune 24, 2025 | msn.comWhalen Wealth Management Inc. Takes Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)June 23, 2025 | marketbeat.comFinal Data from Teva's PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic MigraineJune 23, 2025 | globenewswire.comTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Holdings Reduced by QRG Capital Management Inc.June 20, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd: Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-OncologyJune 18, 2025 | finanznachrichten.deJanney Montgomery Scott LLC Raises Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)June 18, 2025 | marketbeat.comTeva to collaborate with Fosun Pharma for TEV-56278June 17, 2025 | finance.yahoo.comGAMMA Investing LLC Boosts Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)June 17, 2025 | marketbeat.comEliyahu Kalif Sells 55,775 Shares of Teva Pharmaceutical Industries Ltd (TEVA)June 16, 2025 | gurufocus.comHandelsbanken Fonder AB Buys Shares of 15,792 Teva Pharmaceutical Industries Limited (NYSE:TEVA)June 16, 2025 | marketbeat.comBillionaire Stanley Druckenmiller Dumped His Entire Stake in Palantir and Has Piled Into This Suddenly Unstoppable Drug Stock for 3 Straight QuartersJune 16, 2025 | fool.comHennessy Advisors Inc. Sells 74,500 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)June 14, 2025 | marketbeat.comSG Americas Securities LLC Has $5.19 Million Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)June 13, 2025 | marketbeat.com Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address TEVA Media Mentions By Week TEVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEVA News Sentiment▼0.700.96▲Average Medical News Sentiment TEVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEVA Articles This Week▼213▲TEVA Articles Average Week Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TAK News ARGX News ONC News BNTX News INSM News SMMT News ITCI News GMAB News MRNA News RDY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TEVA) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
